Suntrust Banks Inc. cut its stake in Monsanto (NYSE:MON) by 3.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,396 shares of the basic materials company’s stock after selling 983 shares during the quarter. Suntrust Banks Inc.’s holdings in Monsanto were worth $2,845,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently modified their holdings of the company. Bruderman Asset Management LLC bought a new position in shares of Monsanto in the first quarter valued at about $114,000. Private Capital Group LLC raised its position in shares of Monsanto by 1,663.4% in the first quarter. Private Capital Group LLC now owns 1,252 shares of the basic materials company’s stock valued at $146,000 after purchasing an additional 1,181 shares during the period. Elkfork Partners LLC bought a new position in shares of Monsanto in the fourth quarter valued at about $162,000. Truewealth LLC bought a new position in shares of Monsanto in the fourth quarter valued at about $163,000. Finally, Summit Trail Advisors LLC raised its position in shares of Monsanto by 10,659.8% in the first quarter. Summit Trail Advisors LLC now owns 184,100 shares of the basic materials company’s stock valued at $184,000 after purchasing an additional 182,389 shares during the period. 74.99% of the stock is currently owned by institutional investors.
Several brokerages have recently weighed in on MON. Sanford C. Bernstein reissued a “neutral” rating and issued a $119.00 price objective on shares of Monsanto in a research report on Monday, April 9th. Zacks Investment Research lowered shares of Monsanto from a “hold” rating to a “sell” rating in a research report on Monday, April 9th. ValuEngine lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Wednesday, May 2nd. Argus lowered shares of Monsanto from a “buy” rating to a “sell” rating in a research report on Monday, April 16th. Finally, BMO Capital Markets lowered shares of Monsanto from an “outperform” rating to a “market perform” rating in a research report on Tuesday, April 10th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company’s stock. Monsanto currently has an average rating of “Hold” and a consensus price target of $126.49.
Shares of Monsanto opened at $127.95 on Friday, Marketbeat.com reports. The stock has a market cap of $56.40 billion, a price-to-earnings ratio of 23.26, a PEG ratio of 2.64 and a beta of 0.97. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.85 and a current ratio of 1.41. Monsanto has a 12-month low of $114.19 and a 12-month high of $127.97.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Thursday, April 5th. The basic materials company reported $3.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.31 by ($0.09). The firm had revenue of $5.02 billion for the quarter, compared to analyst estimates of $5.34 billion. Monsanto had a return on equity of 37.31% and a net margin of 17.07%. The company’s quarterly revenue was down 1.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.19 earnings per share. analysts predict that Monsanto will post 5.7 EPS for the current fiscal year.
Monsanto Company Profile
Monsanto Company, together with its subsidiaries, provides agricultural products for farmers worldwide. It operates in two segments, Seeds and Genomics, and Agricultural Productivity. The Seeds and Genomics segment produces row crop seeds, including corn, soybean, cotton, and canola seeds under the DEKALB, Asgrow, and Deltapine brands; and vegetable seeds, such as tomato, pepper, melon, cucumber, squash, beans, broccoli, onions, lettuce, and others under the Seminis and De Ruiter brands.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.